Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed May 16, 2016 · 10-Q · 46 days after period end · 0001144204-16-102344
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$2.15M | -$454.25K | -$66.87K | -$337.67K |
| EPS Diluted | -$1.05 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 16, 2016 · 46 d after period end
